Fig. 1From: Chronic hepatitis E infection with an emerging virus strain in a heart transplant recipient successfully treated with ribavirin: a case reporta Liver enzymes, copies of hepatitis E virus ribonucleic acid and b antibodies against hepatitis E virus are shown in days post-heart transplantation. Arrows indicate initiation of ribavirin treatment and dose increase. Alanine aminotransferase (ALT; IU/mL), hepatitis E virus (HEV) ribonucleic acid (RNA; log10/mL), immunoglobulin G (IgG) anti-hepatitis E virus threshold 1.0 and immunoglobulin M (IgM) anti-hepatitis E virus threshold 1.0Back to article page